Class Action Lodged by Pomerantz LLP Against Dow Inc. – DOW

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Dow Inc. ("Dow" or the "Company") (NYSE:DOW) and certain officers.â?¯â?¯ The class action, filed in the United States District Court for the Eastern District of Michigan, Northern Division, and docketed under […]

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged

VisitorsCoverage Partners with Atlys to Deliver Embedded Travel Insurance Technology, Enhancing Global Travel Experience

VisitorsCoverage Inc., an InsurTech100 company and pioneer in digital travel insurance, today announced a strategic partnership with Atlys, a visa processing platform. Through this collaboration, Atlys will integrate VisitorsCoverage's award-winning Treppy™ embedded insurance technology directly into its checkout journey, enabling travelers to seamlessly add comprehensive travel insurance protection while completing their visa applications. https://mma.prnewswire.com/media/2686792/VisitorsCoverage_Logo.jpg Revolutionizing

Pomerantz LLP Pursues Class Action Against Cepton, Inc. – CPTN

NEW YORK, NY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cepton, Inc. ("Cepton" or the "Company") (NASDAQ:CPTN) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08571, is

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zenas BioPharma, Inc. (ZBIO) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zenas BioPharma, Inc. ("Zenas BioPharma" or "the Company") (NASDAQ:ZBIO). Investors who purchased Zenas BioPharma securities prior to September 13, 2024, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Braskem S.A. (BAK) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Braskem S.A. ("Braskem" or "the Company") (NYSE:BAK). Investors who purchased Braskem securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/BAK. Investigation

Anew Climate and Seaspan Energy Complete First Bio-LNG Loading for Maritime Sector, Advancing Maritime Decarbonization

Ship-to-ship fueling operation in Long Beach demonstrates scalable, low-carbon marine fuel solution aligned with global climate goals NORTH VANCOUVER, BC AND HOUSTON, TX, NY / ACCESS Newswire / October 21, 2025 / In another landmark step toward maritime decarbonization, Anew Climate (Anew) and Seaspan Energy (Seaspan) have successfully completed their first ship-to-ship loading operation of

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ:MRVI). Investors who purchased Maravai securities prior to August 7, 2024, and continue to hold to the present, are encouraged to

Cornerstone Bancorp, Inc. Quarterly Report – September 30, 2025

CORNERSTONEBANCORP, INC. THIRD QUARTER 2025 HIGHLIGHTS (At or for period ended 9/30/2025) Income Statement Highlights — Consolidated net income was $2.9 million in 3Q25, or $2.99 per diluted share, compared to $2.6 million in 3Q24, or $2.69 per diluted share. — The net interest margin (NIM) was 3.75% for 3Q25, compared to 3.33% for 3Q24.

BURL CONCEPTS CLOSES CURRENT OVERSUBSCRIBED $4.5 MILLION INVESTMENT

Funding to support launch of non-invasive SONAS® ultrasound system in the Patent Foramen Ovale (PFO) market BURL Concepts, a private MedTech company focused on the development of a state-of-the-art, rapid, automated and affordable test for evaluating cerebral blood flow and detecting emboli, announced today the closing of its most recent funding. The recent funding now

Scroll to Top